MeiraGTx Holdings plc (MGTX) - Dilution Analysis

10-Q filing | 81.3M shares outstanding

8-K filing: MeiraGTx Holdings plc entered into an underwriting agreement for the issuance and sale of 11,111,111 ordinary shares at $9.00 per share, expected to close on April 17, 2026. ($100.0M proceeds)

10-K filing | 80.4M shares outstanding

8-K filing: MeiraGTx Holdings plc repurchased 2,300,000 ordinary shares from Perceptive Life Sciences Master Fund, Ltd. at $7.91 per share, for a total of $18,193,000. ($18.19M proceeds)

10-Q filing | 80.9M shares outstanding

10-Q filing | 79.0M shares outstanding

8-K filing: MeiraGTx Holdings plc entered into a strategic collaboration with Hologen Limited, receiving an upfront cash payment of $200 million and Class A shares of Hologen at a nominal price, while MeiraGTx Neuro UK will receive Class A shares of Hologen Neuro representing a 30% ownership of the issued share capital of Hologen Neuro.

10-K filing | 78.4M shares outstanding

10-Q filing | 71.6M shares outstanding

10-Q filing | 64.4M shares outstanding

10-Q filing | 64.1M shares outstanding

10-K filing | 63.6M shares outstanding

S-3 filing: The company intends to offer and sell up to $250,000,000 in the aggregate of ordinary shares, preferred shares, and purchase contracts from time to time in one or more offerings.

10-Q filing | 59.5M shares outstanding

8-K filing: MeiraGTx Holdings plc entered into an Investment Agreement with Sanofi Foreign Participations B.V. and issued 4,000,000 ordinary shares at $7.50 per share for gross proceeds of $30.0 million. ($30.0M proceeds)

10-Q filing | 55.3M shares outstanding

S-3 filing: This S-3 filing relates to the proposed offering and resale by the selling shareholders of up to an aggregate of 9,144,801 ordinary shares of MeiraGTx Holdings plc.

S-3 filing: This prospectus relates to the proposed offering and resale by the selling shareholder identified in this prospectus of up to an aggregate of 3,742,514 ordinary shares, $0.00003881 par value per share, of MeiraGTx Holdings plc.

10-Q filing | 48.6M shares outstanding

8-K filing: MeiraGTx Holdings plc completed a private placement on May 5, 2023, issuing 10,773,913 ordinary shares at $5.75 per share to accredited investors for gross proceeds of $61,949,999.75. ($61.95M proceeds)

10-K filing | 45.2M shares outstanding

8-K filing: MeiraGTx Holdings plc sold 3,742,514 ordinary shares to Johnson and Johnson Innovation - JJDC, Inc. at a price of $6.68 per share for gross proceeds of approximately $25.0 million in a private placement. ($25.0M proceeds)

10-Q filing | 44.7M shares outstanding

10-Q filing | 44.7M shares outstanding

8-K filing: MeiraGTx Holdings plc granted warrants to Perceptive to purchase up to 400,000 ordinary shares at $15.00 per share and 300,000 ordinary shares at $20.00 per share.

10-Q filing | 44.5M shares outstanding

10-K filing | 44.1M shares outstanding

10-Q filing | 44.2M shares outstanding

10-Q filing | 44.1M shares outstanding

10-Q filing | 44.3M shares outstanding

10-K filing | 44.2M shares outstanding

10-Q filing | 38.4M shares outstanding

10-Q filing | 37.4M shares outstanding

10-Q filing | 37.4M shares outstanding

10-K filing | 36.8M shares outstanding